VC  NanoDimension

https://nd.capital/





     Office Locations:

2983 Woodside Road
Woodside, CA 94062
Phone: 650-241-1155
Fax: 650-529-1381

Get all office locations for this firm with a National Database subscription or Silicon Valley Database subscription.
 

Stages:

  • Early
  • Expansion
  • Growth
  • Seed


 

Industries:

  • Information Technology
  • Life Sciences & Healthcare

  •  

    Description:

    ND Capital (NanoDimension) was started in 2002 with the goal of building a team of truly skilled scientists, investors and entrepreneurs to invest in and to support the growth and commercialization of nanotechnology. The firm targets breakthrough technologies at the nano-scale in the industries of: IT/electronics, life sciences, energy/materials, and the convergence of those three sectors. NanoDimension focuses on early to mid-stage investments, selectively seed and late-stage with an investment size ranging from a few thousand EURO up to EURO 8M per company (including follow-on investments). Nano-Dimension has over $500M under management and is currently investing its $335M third fund. The firm is primarily focused on Europe and North America, maintaining offices in Zurich and Silicon Valley.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Aymeric Sallin Founder & Managing Partner
    Dani Bach Partner
    Eric Moessinger Partner
    Jonathan Nicholson Executive Director of the General Partner
    Kirill Kuzmichev Principal

     

    Portfolio companies include:


      ARMO Biosciences
        web link


      Blend Therapeutics
        web link


      Emulate


      Icosavax


      Inscripta
        web link


      Muse Bio
        web link


      Natron Energy


      Selecta
        web link


      SQZ Biotech
        web link


     

    Recent News: